This study reviews available information on the economics and efficacy of aflatoxin risk-
reduction interventions, and it provides an approach for analysis of the cost-effectiveness of …

Background Despite the existence of effective prevention and treatment interventions,
hepatitis B virus (HBV) infection continues to cause nearly 1 million deaths each year. WHO …

Background Hepatocellular carcinoma (HCC), or liver cancer, is the third leading cause of
cancer deaths worldwide, with prevalence 16–32 times higher in developing countries than …

Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus
(HBV) and is a major global health problem. HBV is the most common serious viral infection …

In this study, we propose new illustrative and effective modeling to point out the behaviors of
the Hepatitis-B virus (Hepatitis-B). Not only do we consider the mathematical modeling …

In this research article, the authors intend to develop and analyze an epidemic model that
describes the progression of acute and chronic HBV in a population. The threshold number …

Hepatitis-B virus infection is globally ubiquitous, but its distribution is very heterogeneous,
with prevalence of serological markers in various nations ranging from less than 1% to more …

Background. The ongoing development of a vaccine against human papillomavirus (HPV)
raises important questions about the impact of various vaccination strategies. Methods. Two …

In this article, we present the transmission dynamic of the acute and chronic hepatitis B
epidemic problem and develop an optimal control strategy to control the spread of hepatitis …

ABSTRACT A mathematical model of the transmission dynamics of infectious disease is an
important theoretical epidemiology method, which has been used to simulate the prevalence …